Controversial Move Sparks Legal Debate and Opposition from Republicans In a bold move aimed at addressing rising pharmaceutical prices, the Biden administration has announced plans to exercise authority over patents of certain high-priced medications developed with federally funded research. This decision, outlined in a regulatory framework issued by the Department of Health and Human Services … Read more